Evidence map›Paper›PMID 22677425›Full record

ArticleOphthalmology2012

Blindness and visual impairment in an urban West African population: the Tema Eye Survey.

Donald L Budenz, Jagadeesh R Bandi, Keith Barton, Winifred Nolan, Leon Herndon, Julia Whiteside-de Vos, Graham Hay-Smith, Hanna Kim, James Tielsch, Tema Eye Survey Study Group

Abstract read
In one paragraph

Article in Ophthalmology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. [Visual Impairment and Eye Diseases in St. Louis, Senegal].Medecine tropicale et sante internationale · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Donald L BudenzDepartment of Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA. dbudenz@med.unc.edu
Jagadeesh R Bandi
Keith Barton
Winifred Nolan
Leon Herndon
Julia Whiteside-de Vos
Graham Hay-Smith
Hanna Kim
James Tielsch
Tema Eye Survey Study Group
Duke University · USNIHR Biomedical Research Centre at The Royal Marsden and the ICRUniversity of Miami · USBirmingham and Midland Eye Centre · GBJohns Hopkins University · USUniversity of North Carolina at Chapel Hill · US

Funding

CLINICAL TRIALS TRAINING PROGRAM IN VISION RESEARCHT32EY007127 · NEI · JOHNS HOPKINS UNIVERSITY · PI MEINERT, CURTIS L · 1991 to 2010
$4.7M
NEI NIH HHS T32 EY007127NEI NIH HHS T32EY-07127
6 · The paper itself

Abstract

objectiveTo determine the prevalence, causes, and risk factors of blindness and visual impairment among persons aged 40 years or older residing in an urban West African location.

designPopulation-based, cross-sectional study.

participantsA total of 5603 participants residing in Tema, Ghana.

methodsProportionate random cluster sampling was used to select participants aged 40 years or older living in the city of Tema. Presenting distance visual acuity (VA) was measured at 4 and 1 m using a reduced logarithm of the minimum angle of resolution tumbling E chart and then with trial frame based on autorefraction. A screening examination was performed in the field on all participants. Complete clinical examination by an ophthalmologist was performed on participants with best-corrected visual acuity (BCVA) <20/40 or failure of any screening test.

main outcome measuresAge- and gender-specific prevalence, causes, and risk factors for blindness (VA of <20/400 in the better eye, World Health Organization definition) and visual impairment (VA of <20/40 in the better eye).

resultsA total of 6806 eligible participants were identified, of whom 5603 (82.3%) participated in the study. The mean age (± standard deviation) of participants was 52.7 ± 1 0.9 years. The prevalence of visual impairment and blindness was 17.1% and 1.2%, respectively. After refraction and spectacle correction, the prevalence of visual impairment and blindness decreased to 6.7% and 0.75%, respectively, suggesting that refractive error is the major correctable cause of visual impairment and blindness in this population. Of 65 subjects with a VA <20/400, 22 (34%) were correctable with refraction, 21 to the level of visual impairment and 1 to normal. The remaining 43 patients (66%) had underlying pathology (cataract in 19, glaucoma in 9, nonglaucomatous optic neuropathy in 3, corneal opacities in 3, retinal disease in 3, and undetermined in 5) that prevented refractive correction. Increased age was a significant risk factor for blindness and visual impairment.

conclusionsThere is a high prevalence of blindness and visual impairment among those aged ≥ 40 years in Tema, Ghana, West Africa. Refractive error is a major cause of blindness and visual impairment in this population, followed by cataract, glaucoma, and corneal disease.

Indexed as

AdultAgedAged, 80 and overAge DistributionBlindnessCross-Sectional StudiesFemaleGhanaHealth SurveysHumansMaleMiddle AgedPersons with Visual DisabilitiesPrevalenceRefractive ErrorsRisk Factors

Identifiers

PMID22677425
PMCPMC3532814
OpenAlexW2147039388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.